Shoreline Biome Announces Name Change to Intus Biosciences
Retrieved on:
Thursday, October 27, 2022
FARMINGTON, Conn., Oct. 27, 2022 /PRNewswire-PRWeb/ -- Shoreline Biome, the developer of the industry-leading Titan-1TM microbiome research, discovery and testing platform, announced today that it has changed its name to Intus Biosciences.
Key Points:
- FARMINGTON, Conn., Oct. 27, 2022 /PRNewswire-PRWeb/ -- Shoreline Biome, the developer of the industry-leading Titan-1TM microbiome research, discovery and testing platform, announced today that it has changed its name to Intus Biosciences .
- The change marks Intus Biosciences' strategic transformation from supplying research tools to providing complete data-driven solutions for microbiome discovery and understanding.
- Intus Biosciences' groundbreaking platform is a combination of patented assays and advanced proprietary analysis tools.
- "This is an incredibly exciting time for our company and the amazing team behind it," said Paul Denslow, Intus Biosciences' CEO.